Search Result "and Ts65Dn mice."
Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome
Journal: Current Alzheimer Research
Volume: 13 Issue: 1 Year: 2016 Page: 84-96
Author(s): Christy M. Kelley,Jessica A. Ash,Brian E. Powers,Ramon Velazquez,Melissa J. Alldred,Milos D. Ikonomovic,Stephen D. Ginsberg,Barbara J. Strupp,Elliott J. Mufson
Lithium Restores Age-related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 7 Year: 2017 Page: 812-819
Author(s): Sandra Guidi,Patrizia Bianchi,Fiorenza Stagni,Andrea Giacomini,Marco Emili,Stefania Trazzi,Elisabetta Ciani,Renata Bartesaghi
Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease
Journal: Current Alzheimer Research
Volume: 14 Issue: 12 Year: 2017 Page: 1305-1317
Author(s): A. Arena,A. M. Iyer,I. Milenkovic,G. G. Kovacs,I. Ferrer,M. Perluigi,E. Aronica
Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimerâs Disease
Journal: Current Alzheimer Research
Volume: 13 Issue: 1 Year: 2016 Page: 97-106
Author(s): Barbara J. Strupp,Brian E. Powers,Ramon Velazquez,Jessica A. Ash,Christy M. Kelley,Melissa J. Alldred,Myla Strawderman,Marie A. Caudill,Elliott J. Mufson,Stephen D. Ginsberg
Mouse Models of Down Syndrome and Alzheimerâs Disease: Similarities and Differences
Ebook: Recent Advances in Alzheimer Research
Volume: 1 Year: 2015
Author(s): Noemà Rueda,Carmen MartÃnez-Cué
Doi: 10.2174/9781681081380115010013
Pharmacotherapy of Downâs Syndrome: When and Which?
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 18 Issue: 10 Year: 2019 Page: 750-757
Author(s): Seyed K. Tayebati,Alessandro Cecchi,Ilenia Martinelli,Elisa Carboni,Francesco Amenta
The Akt-mTOR Pathway in Downâs Syndrome: The Potential Use of Rapamycin/Rapalogs for Treating Cognitive Deficits
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 1 Year: 2014 Page: 34-40
Author(s): Jose Antonio Troca-Marin,Juan Jose Casanas,Itziar Benito,Maria Luz Montesinos
The Glutamatergic Hypothesis for Down Syndrome: The Potential Use of N-Methyl-D-Aspartate Receptor Antagonists to Enhance Cognition and Decelerate Neurodegeneration
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 1 Year: 2014 Page: 16-25
Author(s): Alberto C.S. Costa
Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome
Journal: Current Alzheimer Research
Volume: 13 Issue: 1 Year: 2016 Page: 35-52
Author(s): Eric D. Hamlett,Heather A. Boger,Aurélie Ledreux,Christy M. Kelley,Elliott J. Mufson,Maria F. Falangola,David N. Guilfoyle,Ralph A. Nixon,David Patterson,Nathan Duval,Ann-Charlotte E. Granholm
Noradrenergic System in Down Syndrome and Alzheimerâs Disease A Target for Therapy
Journal: Current Alzheimer Research
Volume: 13 Issue: 1 Year: 2016 Page: 68-83
Author(s): Cristy Phillips,Atoossa Fahimi,Devsmita Das,Fatemeh S. Mojabi,Ravikumar Ponnusamy,Ahmad Salehi